New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid
Grania Brigden,1 Cathy Hewison,2 Francis Varaine21Access Campaign, Médecins Sans Frontières, Geneva, Switzerland; 2Medical Department, Médecins Sans Frontières, Paris, France Abstract: The current treatment for drug-resistant tuberculosis (TB) is long, co...
Main Authors: | Brigden G, Hewison C, Varaine F |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-10-01
|
Series: | Infection and Drug Resistance |
Online Access: | https://www.dovepress.com/new-developments-in-the-treatment-of-drug-resistant-tuberculosis-clini-peer-reviewed-article-IDR |
Similar Items
-
Advances of new drugs bedaquiline and delamanid in the treatment of multi-drug resistant tuberculosis in children
by: Hanzhao Zhu, et al.
Published: (2023-06-01) -
Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Children: The Role of Bedaquiline and Delamanid
by: Francesco Pecora, et al.
Published: (2021-05-01) -
Prevalence of Mycobacterium tuberculosis resistant to bedaquiline and delamanid in China
by: Wencong He, et al.
Published: (2021-09-01) -
Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis
by: Andrey Maryandyshev, et al.
Published: (2017-10-01) -
Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB
by: James Millard, et al.
Published: (2023-05-01)